Altshuler Shaham’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.68K | Buy |
19,211
+4
| +0% | +$4.05K | ﹤0.01% | 366 |
|
|
2025
Q4 | $0 | Hold |
19,207
| – | – | ﹤0.01% | 441 |
|
|
2025
Q3 | $0 | Hold |
19,207
| – | – | ﹤0.01% | 392 |
|
|
2025
Q2 | $0 | Hold |
19,207
| – | – | ﹤0.01% | 347 |
|
|
2025
Q1 | $0 | Hold |
19,207
| – | – | ﹤0.01% | 367 |
|
|
2024
Q4 | $0 | Buy |
+19,207
| New | +$15.9M | ﹤0.01% | 400 |
|
|
2024
Q3 | – | Sell |
-19,207
| Closed | – | – | 346 |
|
|
2024
Q2 | $0 | Hold |
19,207
| – | – | ﹤0.01% | 330 |
|
|
2024
Q1 | $0 | Sell |
19,207
-112
| -0.6% | -$79.7K | ﹤0.01% | 342 |
|
|
2023
Q4 | $65.3K | Sell |
19,319
-29
| -0.1% | -$16.9K | ﹤0.01% | 101 |
|
|
2023
Q3 | $75.7K | Sell |
19,348
-72
| -0.4% | -$37.1K | ﹤0.01% | 109 |
|
|
2023
Q2 | $99.9K | Buy |
19,420
+116
| +0.6% | +$48.6K | ﹤0.01% | 123 |
|
|
2023
Q1 | $33.3K | Sell |
19,304
-341
| -2% | -$115K | ﹤0.01% | 236 |
|
|
2022
Q4 | $160K | Sell |
19,645
-199
| -1% | -$70.6K | 0.01% | 104 |
|
|
2022
Q3 | $210K | Buy |
19,844
+401
| +2% | +$127K | 0.01% | 123 |
|
|
2022
Q2 | $77K | Sell |
19,443
-12,163
| -38% | -$3.65M | ﹤0.01% | 187 |
|
|
2022
Q1 | $95K | Sell |
31,606
-175
| -0.6% | -$45K | ﹤0.01% | 269 |
|
|
2021
Q4 | $140K | Buy |
31,781
+7
| +0% | +$1.77K | ﹤0.01% | 290 |
|
|
2021
Q3 | $116K | Buy |
31,774
+7
| +0% | +$1.73K | ﹤0.01% | 307 |
|
|
2021
Q2 | $113K | Buy |
31,767
+269
| +0.9% | +$54K | ﹤0.01% | 309 |
|
|
2021
Q1 | $42K | Buy |
+31,498
| New | +$6.16M | ﹤0.01% | 312 |
|
|
2020
Q4 | – | Sell |
-217
| Closed | -$32K | – | 434 |
|
|
2020
Q3 | $32K | Sell |
217
-2,844
| -93% | -$440K | ﹤0.01% | 272 |
|
|
2020
Q2 | $503K | Sell |
3,061
-779
| -20% | -$120K | 0.02% | 99 |
|
|
2020
Q1 | $533K | Buy |
3,840
+3,722
| +3,154% | +$511K | 0.02% | 83 |
|
|
2019
Q4 | $16K | Buy |
118
+33
| +39% | +$3.83K | ﹤0.01% | 278 |
|
|
2019
Q3 | $9K | Sell |
85
-2
| -2% | -$223 | ﹤0.01% | 301 |
|
|
2019
Q2 | $10K | Sell |
87
-61
| -41% | -$7.18K | ﹤0.01% | 297 |
|
|
2019
Q1 | $19K | Buy |
148
+78
| +111% | +$9.48K | ﹤0.01% | 187 |
|
|
2018
Q4 | $8K | Buy |
70
+3
| +4% | +$335 | ﹤0.01% | 202 |
|
|
2018
Q3 | $7K | Buy |
+67
| New | +$6.7K | ﹤0.01% | 213 |
|
|
2018
Q2 | – | Sell |
-25,531
| Closed | -$1.98M | – | 240 |
|
|
2018
Q1 | $1.98M | Buy |
25,531
+599
| +2% | +$48.2K | 0.26% | 48 |
|
|
2017
Q4 | $2.11M | Buy |
+24,932
| New | +$2.12M | 0.3% | 37 |
|
Other funds holding LLY
VCM
VPM
Altshuler Shaham's LLY Position: Q1 2026 in Review
Altshuler Shaham increased its Eli Lilly (LLY) stake by 0.02% in Q1 2026, buying an estimated $4.05K and bringing the position to 19,211 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #366.
Altshuler Shaham first reported a position in LLY in Q4 2017 and has held it in 31 quarters since. The position peaked at $2.11M in Q4 2017. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Altshuler Shaham held 19,211 shares of Eli Lilly worth $3.68K as of Q1 2026.
- Altshuler Shaham bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
- Eli Lilly made up ﹤0.01% of Altshuler Shaham's portfolio in Q1 2026, its #366 holding.
- Altshuler Shaham first reported a position in Eli Lilly in Q4 2017 and has held it in 31 quarters since.
- Altshuler Shaham's Eli Lilly position peaked at $2.11M in Q4 2017.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.